Skip to content
Clinical Trials – home
Research site

Studienzentrum Dr. Braun GmbH

Germany Breite Strasse 41, Pankow, 13187 Berlin, Germany

  • 1 trial recruiting
  • Chronic kidney disease · Obesity · Overweight
  • Adult patients

About Specializations

Studienzentrum Dr. Braun GmbH in Berlin, Germany specialises in clinical trials of conditions such as Chronic kidney disease, Obesity, Overweight, and other specialisations. This site conducts important research.

Main research areas of the site

Cardiovascular Diseases

At Studienzentrum Dr. Braun GmbH, research focuses on chronic kidney disease within the cardiovascular field, aiming to assess new therapies that may slow kidney function decline and improve overall patient outcomes.

  • Evaluation of novel agents for renal protection
  • Impact on eGFR decline and end‑stage kidney disease
  • Safety profile of emerging cardiovascular drugs

The site’s integrated approach combines cardiology and nephrology expertise to advance patient care in Berlin.

Nutritional and Metabolic Diseases

Studies at the center also target chronic weight management, evaluating long‑term efficacy and safety of injectable therapies designed to support sustained weight loss.

  • Long‑term effectiveness of weight‑loss agents
  • Assessment of metabolic health improvements
  • Safety and tolerability in diverse adult populations

These trials reflect the clinic’s commitment to addressing metabolic health challenges within the community.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Breite Strasse 41, Pankow13187 BerlinGermany
Recruiting now
1 trial
Conditions studied
3

More sites in BerlinGermany

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

2 clinical trials

Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Azd5004
  • Sponsor:AstraZeneca AB

Obesity+1

Not yet recruiting
Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Maridebart Cafraglutide
  • Sponsor:Amgen Inc.
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.